Cargando…
Establishing Patient-Centered Outcomes for MCT8 Deficiency: Stakeholder Engagement and Systematic Literature Review
INTRODUCTION: The SCL16A2 gene encodes the thyroid hormone (TH) transporter MCT8. Pathogenic variants result in a reduced TH uptake into the CNS despite high serum T3 concentrations. Patients suffer from severe neurodevelopmental delay and require multidisciplinary care. Since a first compassionate...
Autores principales: | Wilpert, Nina-Maria, Tonduti, Davide, Vaia, Ylenia, Krude, Heiko, Sarret, Catherine, Schuelke, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595182/ https://www.ncbi.nlm.nih.gov/pubmed/37881807 http://dx.doi.org/10.2147/NDT.S379703 |
Ejemplares similares
-
Intranasal delivery of Thyroid hormones in MCT8 deficiency
por: Grijota-Martínez, Carmen, et al.
Publicado: (2020) -
MCT8 Deficiency: The Road to Therapies for a Rare Disease
por: Grijota-Martínez, Carmen, et al.
Publicado: (2020) -
Genetic and Neurological Deficiencies in the Visual System of mct8 Mutant Zebrafish
por: Rozenblat, Rotem, et al.
Publicado: (2022) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021) -
Hypotonic male infant and MCT8 deficiency - a diagnosis to think about
por: Rodrigues, Filipa, et al.
Publicado: (2014)